| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2012aae8b8756125ba3ae2063cdcaee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72045d20a99e7e448259d7bc8d95c497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd957b09deaef13fcba6fc012ed26d48 |
| publicationDate |
2010-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7696248-B2 |
| titleOfInvention |
Glucagon receptor antagonists, preparation and therapeutic uses |
| abstract |
The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324140-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011124648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609892-B2 |
| priorityDate |
2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |